APOE and Alzheimer disease: Reduced levels of SORL1 have been observed in neural stem cells from APOE ε4/4 carriers (Zollo et al., 2017), whereas increased levels have been detected in cerebrospinal fluid (CSF) of AD patients (Ikeuchi et al., 2010).